Inmune Bio Inc. (INMB)
NCM · Common · CUSIP 45782T105
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for INMB and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
45782T105
Market Cap
Micro Cap
IPO
2/4/2019 · $8.00/share
Business: Inmune Bio Inc. is a clinical-stage biotechnology company developing therapies targeting the innate immune system in cancer.

Company Contact

CEO
Raymond J. Tesi
CFO
David J. Moss
Headquarters
225 NE Mizner Blvd., Suite 640, Boca Raton, FL 33432
Phone
858-964-3720
Investor Relations
David Moss · 858-964-3720 · dmoss@inmunebio.com
SEC EDGAR Filings
View filings »